5 Key Takeaways
-
1
Diverse representation in clinical trials enhances understanding of treatment responses and reduces health disparities.
-
2
Black and Hispanic populations are often underrepresented in clinical trials despite higher prevalence of certain eye disorders.
-
3
Mistrust in healthcare, rooted in historical mistreatment, significantly contributes to the underrepresentation of racial and ethnic minorities.
-
4
Community engagement and trust-building with local leaders can improve clinical trial enrollment among underserved populations.
-
5
Understanding and addressing barriers to participation can enhance diversity in clinical trial recruitment efforts.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







